The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Antifibrotic action of pirfenidone and prednisolone: Different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Woessner, J. F. (1961) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(61)90291-0 · Cited by 3,840
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
Interleukin-1 and interleukin-1 antagonism
Dinarello, C. (1991) · Blood · doi:10.1182/blood.v77.8.1627.1627 · Cited by 2,304
Selman, M., King, T. E., & Pardo, A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-2-200101160-00015 · Cited by 1,786
Simple method of estimating severity of pulmonary fibrosis on a numerical scale.
Ashcroft, T., Simpson, J. M., & Timbrell, V (1988) · Journal of Clinical Pathology · doi:10.1136/jcp.41.4.467 · Cited by 1,680
Interleukin-18 Regulates Both Th1 and Th2 Responses
Nakanishi, K., Yoshimoto, T., Tsutsui, H., & Okamura, H. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.423 · Cited by 1,315
Thomson, A. W. (1994) · Cited by 1,116
Gross, T. J., & Hunninghake, G. W. (2001) · New England Journal of Medicine · doi:10.1056/nejmra003200 · Cited by 962
Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Azuma, A., Nukiwa, T., Tsuboi, E., Suga, M., Abe, S., Nakata, K., Taguchi, Y., Nagai, S., Itoh, H., Ohi, M., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200404-571oc · Cited by 954
Lee, C. G., Homer, R. J., Zhu, Z., Lanone, S., Wang, X., Koteliansky, V., Shipley, J. M., Gotwals, P., Noble, P., Chen, Q., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.809 · Cited by 940
Bone marrow–derived progenitor cells in pulmonary fibrosis
Hashimoto, N., Jin, H., Liu, T., Chensue, S. W., & Phan, S. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18847 · Cited by 720
Staub, N. C. (1974) · Physiological Reviews · doi:10.1152/physrev.1974.54.3.678 · Cited by 672
A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis
Raghu, G., Brown, K. K., Bradford, W. Z., Starko, K., Noble, P. W., Schwartz, D. A., & King, T. E. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030511 · Cited by 652
Ziesche, R., Hofbauer, E., Wittmann, K., Petkov, V., & Block, L.-H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910213411703 · Cited by 586
Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis.
Piguet, P. F., Collart, M. A., Grau, G. E., Kapanci, Y., & Vassalli, P. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.3.655 · Cited by 583
RAGHU, G., CRAIG JOHNSON, W., LOCKHART, D., & MAGETO, Y. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.4.9805017 · Cited by 468
Acute Exacerbation in Idiopathic Pulmonary Fibrosis
Kondoh, Y., Taniguchi, H., Kawabata, Y., Yokoi, T., Suzuki, K., & Takagi, K. (1993) · Chest · doi:10.1378/chest.103.6.1808 · Cited by 457
Platelet-derived growth factor in idiopathic pulmonary fibrosis.
Antoniades, H. N., Bravo, M. A., Avila, R. E., Galanopoulos, T., Neville-Golden, J., Maxwell, M., & Selman, M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114808 · Cited by 384
Iyer, S. N., Gurujeyalakshmi, G., & Giri, S. N. (1999) · PubMed · Cited by 358
Pharmacologic Differentiation of Inflammation and Fibrosis in the Rat Bleomycin Model
Chaudhary, N. I., Schnapp, A., & Park, J. E. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200505-717oc · Cited by 358
Lung Cytokine Production in Bleomycin-Induced Pulmonary Fibrosis
Phan, S. H., & Kunkel, S. L. (1992) · Experimental Lung Research · doi:10.3109/01902149209020649 · Cited by 323
Gurujeyalakshmi, G., & Giri, S. N. (1995) · Experimental Lung Research · doi:10.3109/01902149509050842 · Cited by 303
Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival
Turner-Warwick, M., Burrows, B., & Johnson, A. (1980) · Thorax · doi:10.1136/thx.35.8.593 · Cited by 244
In vivo production and function of IL-12 p40 homodimers
Heinzel, F. P., Hujer, A. M., Ahmed, F. N., & Rerko, R. M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.9.4381 · Cited by 229
Dietary intake of pirfenidone ameliorates bleomycin-induced lung fibrosis in hamsters.
Iyer, S. N., Wild, J. S., Schiedt, M. J., Hyde, D. M., Margolin, S. B., & Giri, S. N. (1995) · PubMed · Cited by 217
Yang, G., Volk, A., Petley, T., Emmell, E., Giles-Komar, J., Shang, X., Li, J., Das, A. M., Shealy, D., Griswold, D. E., et al. (2004) · Cytokine · doi:10.1016/j.cyto.2004.08.007 · Cited by 192
Pathogenetic mechanisms in usual interstitial pneumonia/idiopathic pulmonary fibrosis
White, E. S., Lazar, M. H., & Thannickal, V. J. (2003) · The Journal of Pathology · doi:10.1002/path.1446 · Cited by 190
Khalil, N., Whitman, C., Zuo, L., Danielpour, D., & Greenberg, A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116771 · Cited by 186
Iyer, S. N., Gurujeyalakshmi, G., & Giri, S. N. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35110-9 · Cited by 181
Gurujeyalakshmi, G., Hollinger, M. A., & Giri, S. N. (1999) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1999.276.2.l311 · Cited by 179
Iyer, S. N., Gurujeyalakshmi, G., & Giri, S. N. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38125-x · Cited by 179
Potential action of IL-4 and IL-13 as fibrogenic factors on lung fibroblasts in vitro
Saito, A., Okazaki, H., Sugawara, I., Yamamoto, K., & Takizawa, H. (2003) · International Archives of Allergy and Immunology · doi:10.1159/000073718 · Cited by 167
Pirfenidone attenuates expression of HSP47 in murine bleomycin-induced pulmonary fibrosis
Kakugawa, T., Mukae, H., Hayashi, T., Ishii, H., Abe, K., Fujii, T., Oku, H., Miyazaki, M., Kadota, J., & Kohno, S. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00120803 · Cited by 166
Self-citationMauviel, A. (2005) · Humana Press eBooks · doi:10.1385/1-59259-940-0:069 · Cited by 159
Oku, H., Nakazato, H., Horikawa, T., Tsuruta, Y., & Suzuki, R. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01757-0 · Cited by 159
Self-citationHuman mast cell basic fibroblast growth factor in pulmonary fibrotic disorders.
Inoue, Y., King, T. E., Tinkle, S. S., Dockstader, K., & Newman, L. S. (1996) · Europe PMC (PubMed Central) · Cited by 155
Anti-Inflammatory Effect of Pirfenidone in the Bleomycin-Hamster Model of Lung Inflammation
Iyer, S. N., Hyde, D. M., & Giri, S. N. (2000) · Inflammation · doi:10.1023/a:1007068313370 · Cited by 144
Introduction of the interleukin-10 gene into mice inhibited bleomycin-induced lung injury in vivo
Arai, T., Abe, K., Matsuoka, H., Yoshida, M., Mori, M., Goya, S., Kida, H., Nishino, K., Osaki, T., Tachibana, I., et al. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.278.5.l914 · Cited by 141
Pirfenidone inhibits NADPH-dependent microsomal lipid peroxidation and scavenges hydroxyl radicals
Misra, H. P., & Rabideau, C. L. (2000) · Molecular and Cellular Biochemistry · doi:10.1023/a:1007023532508 · Cited by 135
Nagai, S., HAMADA, K., Shigematsu, M., TANIYAMA, M., Yamauchi, S., & Izumi, T. (2002) · Internal Medicine · doi:10.2169/internalmedicine.41.1118 · Cited by 134
Inoue, Y., King, T. E., Barker, E. P., Daniloff, E., & Newman, L. S. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2010014 · Cited by 130
Demystifying Idiopathic Interstitial Pneumonia
Collard, H. R., & King, T. E. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.1.17 · Cited by 110
Enhanced Expression of Interleukin-18 and its Receptor in Idiopathic Pulmonary Fibrosis
Kitasato, Y., Hoshino, T., Okamoto, M., Kato, S., Koda, Y., Nagata, N., Kinoshita, M., Koga, H., Yoon, D., Asao, H., et al. (2004) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0306oc · Cited by 97
A Profibrotic Function of IL-12p40 in Experimental Pulmonary Fibrosis
Huaux, F., Arras, M., Tomasi, D., Barbarin, V., Delos, M., Coutelier, J., Vink, A., Phan, S. H., Renauld, J., & Lison, D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2653 · Cited by 86
Pirfenidone diminishes cyclophosphamide-induced lung fibrosis in mice
Kehrer, J. P., & Margolin, S. B. (1997) · Toxicology Letters · doi:10.1016/s0378-4274(96)03845-3 · Cited by 81
Kotaro, T., Taooka, Y., Maeda, A., Hiyama, K., Ishioka, S., & Yamakido, M. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.4.9906099 · Cited by 71
Serologic analysis of the mouse beta chemokine JE/monocyte chemoattractant protein-1.
Luo, Y., Laning, J. C., Hayashi, M., Hancock, P. R., Rollins, B. J., & Dorf, M. E. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.8.3708 · Cited by 41
Interleukin-6, Interferon-Gamma, and Phospholipid Levels in the Alveolar Lining Fluid of Human Lungs
Lesur, O., Mancini, N., Humbert, J. C., Chabot, F., & Polu, J. M. (1994) · CHEST Journal · doi:10.1378/chest.106.2.407 · Cited by 35
Entzian, P., Zähringer, U., Schlaak, M. S., Gerlach, C., Galle, J., & Zabel, P. (1998) · International Journal of Immunopharmacology · doi:10.1016/s0192-0561(98)00056-3 · Cited by 25
Pharmacokinetics of orally administered pirfenidone in male and female beagles
Bruss, M. L., Margolin, S. B., & Giri, S. N. (2004) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/j.1365-2885.2004.00612.x · Cited by 22
THE EFFECT OF ENOXAPARIN ON BLEOMYCIN-INDUCED LUNG INJURY IN MICE
Lossos, I. S. (1999) · Experimental Lung Research · doi:10.1080/019021499270114 · Cited by 21
Mechanisms of antifibrotic action of interferon gamma-1b in pulmonary fibrosis.
Ziesche, R., & Block, L. H. (2000) · PubMed · Cited by 9
Interferon-γ 1b: impact of new indications (idiopathic pulmonary fibrosis)
Aggarwal, A. N., & Behera, D. (2000) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.1.7.1423 · Cited by 8
Cited by
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
Noble, P. W., Albera, C., Bradford, W. Z., Costabel, U., Glassberg, M. K., Kardatzke, D., King, T. E., Lancaster, L., Sahn, S. A., Szwarcberg, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60405-4 · Cited by 2,154
Raghu, G., Rochwerg, B., Zhang, Y., Garcia, C. A. C., Azuma, A., Behr, J., Brozek, J. L., Collard, H. R., Cunningham, W., Homma, S., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201506-1063st · Cited by 1,916
Pirfenidone in idiopathic pulmonary fibrosis
Taniguchi, H., Ebina, M., Kondoh, Y., Ogura, T., Azuma, A., Suga, M., Taguchi, Y., Takahashi, H., Nakata, K., Sato, A., et al. (2010) · European Respiratory Journal · doi:10.1183/09031936.00005209 · Cited by 946
Pirfenidone in idiopathic pulmonary fibrosis: Figure 1–
Swigris, J., & Fairclough, D. (2010) · European Respiratory Journal · doi:10.1183/09031936.00071710 · Cited by 799
The Role of IL-6 in Skin Fibrosis and Cutaneous Wound Healing
Johnson, B. Z., Stevenson, A. W., Prêle, C. M., Fear, M. W., & Wood, F. M. (2020) · Biomedicines · doi:10.3390/biomedicines8050101 · Cited by 529
Metadata
- Authors
- Oku, H., Shimizu, T., Kawabata, T., Nagira, M., Hikita, I., Ueyama, A., Matsushima, S., Torii, M., & Arimura, A.
- Venue
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Published
- 2008-08
- Volume
- 590
- Issue
- 1-3
- Pages
- 400-408
- ISSN
- 0014-2999 (ISSN-L)
- OpenAlex
- W2085604666
- Cited by
- 436
- References
- 54
- FWCI
- 10.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.